Bnp Paribas Asset Management Holding S.A. Nuvalent, Inc. Transaction History
Bnp Paribas Asset Management Holding S.A.
- $41 Billion
- Q2 2025
A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Nuvalent, Inc. stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 311 shares of NUVL stock, worth $23,048. This represents 0.0% of its overall portfolio holdings.
Number of Shares
311Holding current value
$23,048% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NUVL
# of Institutions
218Shares Held
60.9MCall Options Held
311KPut Options Held
175K-
Deerfield Management Company, L.P. (Series C) New York, NY18MShares$1.33 Billion32.3% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY5.27MShares$391 Million19.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.44MShares$329 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.02MShares$224 Million0.01% of portfolio
-
Commodore Capital LP New York, NY1.86MShares$137 Million12.88% of portfolio
About Nuvalent, Inc.
- Ticker NUVL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,977,800
- Market Cap $3.19B
- Description
- Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferr...